180 Life Sciences Corp. Quarterly Debt-to-equity in % from Q1 2018 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
180 Life Sciences Corp. quarterly Debt-to-equity history and growth rate from Q1 2018 to Q3 2024.
  • 180 Life Sciences Corp. Debt-to-equity for the quarter ending September 30, 2024 was 933 %, a 731% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 933 +821 +731% Sep 30, 2024
Q2 2024 -1.17K -1.23K -2009% Jun 30, 2024
Q1 2024 398 +358 +896% Mar 31, 2024
Q4 2023 186 +148 +390% Dec 31, 2023
Q3 2023 112 +71.5 +175% Sep 30, 2023
Q2 2023 61 +10.7 +21.2% Jun 30, 2023
Q1 2023 40 -63 -61.2% Mar 31, 2023
Q4 2022 37.9 -102 -72.9% Dec 31, 2022
Q3 2022 40.9 -114 -73.6% Sep 30, 2022
Q2 2022 50.4 -84 -62.5% Jun 30, 2022
Q1 2022 103 +44.2 +75.2% Mar 31, 2022
Q4 2021 140 +108 +344% Dec 31, 2021
Q3 2021 155 +134 +625% Sep 30, 2021
Q2 2021 134 +107 +387% Jun 30, 2021
Q1 2021 58.8 +19.4 +49.2% Mar 31, 2021
Q4 2020 31.5 -26 -45.3% Dec 31, 2020
Q3 2020 21.4 -280 -92.9% Sep 30, 2020
Q2 2020 27.6 -244 -89.9% Jun 30, 2020
Q1 2020 39.4 -223 -85% Mar 31, 2020
Q4 2019 57.5 -192 -77% Dec 31, 2019
Q3 2019 301 +211 +235% Sep 30, 2019
Q2 2019 272 +184 +210% Jun 30, 2019
Q1 2019 262 +178 +210% Mar 31, 2019
Q4 2018 250 Dec 31, 2018
Q3 2018 89.8 Sep 30, 2018
Q2 2018 87.7 Jun 30, 2018
Q1 2018 84.6 Mar 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.